15. Redeemable Noncontrolling Interests and Total Equity.
Redeemable Noncontrolling Interests.
Redeemable noncontrolling interests related to the Wealth Management JV (see Note 3). Changes in redeemable noncontrolling interests for 2013 and 2012 were as follows:
2013 | 2012 | ||||
(dollars in millions) | |||||
Balance at beginning of period | $ | 4,309 | $ | — | |
Reclassification from nonredeemable noncontrolling interests | — | 4,288 | |||
Net income applicable to redeemable noncontrolling interests | 222 | 124 | |||
Net change in AOCI | — | (2) | |||
Distributions | (38) | (97) | |||
Other | (11) | (4) | |||
Carrying value of additional stake in Wealth Management JV purchased from Citi | (4,482) | — | |||
Balance at end of period | $ | — | $ | 4,309 |
Total Equity.
Morgan Stanley Shareholders' Equity.
Common Stock. Changes in shares of common stock outstanding for 2013, 2012 and 2011 were as follows (share data in millions):
2013 | 2012 | 2011 | |||||
Shares outstanding at beginning of period | 1,974 | 1,927 | 1,512 | ||||
Public offerings and other issuances of common stock | — | — | 385 | ||||
Net impact of other share activity | (2) | 60 | 41 | ||||
Treasury stock purchases(1) | (27) | (13) | (11) | ||||
Shares outstanding at end of period | 1,945 | 1,974 | 1,927 |
____________
(1) Treasury stock purchases include repurchases of common stock for employee tax withholding.
Treasury Shares. In July 2013, the Company received no objection from the Federal Reserve to repurchase through March 31, 2014 up to $500 million of the Company's outstanding common stock under rules relating to annual capital distributions (Title 12 of the Code of Federal Regulations, Section 225.8, Capital Planning). Share repurchases are made pursuant to the share repurchase program previously authorized by the Company's Board of Directors and are exercised from time to time at prices the Company deems appropriate subject to various factors, including the Company's capital position and market conditions. The share repurchases may be effected through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans, and may be suspended at any time (see “Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities” in Part II, Item 5).
During 2013, the Company repurchased approximately $350 million of the Company's outstanding common stock as part of its share repurchase program. During 2012, the Company did not repurchase common stock as part of its share repurchase program. At December 31, 2013, the Company had approximately $1.2 billion remaining under its share repurchase program out of the $6 billion authorized by the Board of Directors in December 2006. The share repurchase program considers, among other things, business segment capital needs, as well as equity-based compensation and benefit plan requirements. Share repurchases by the Company are subject to regulatory approval.
MUFG Stock Conversion. On June 30, 2011, the Company's outstanding Series B Preferred Stock owned by MUFG with a face value of $7.8 billion (carrying value $8.1 billion) and a 10% dividend was converted into 385,464,097 shares of Company common stock, including approximately 75 million shares resulting from the adjustment to the conversion ratio pursuant to the transaction agreement. As a result of the adjustment to the conversion ratio, the Company incurred a one-time, non-cash negative adjustment of approximately $1.7 billion in its calculation of basic and diluted earnings per share during 2011.
Employee Stock Trusts. The Company has established Employee Stock Trusts to provide common stock voting rights to certain employees who hold outstanding RSUs, excluding the awards granted for 2012 performance year. The assets of the Employee Stock Trusts are consolidated with those of the Company, and the value of the Company's stock held in the Employee Stock Trusts is classified in Morgan Stanley shareholders' equity and generally accounted for in a manner similar to treasury stock.
Preferred Stock. The Company is authorized to issue 30 million shares of preferred stock and the Company's preferred stock outstanding consisted of the following:
Carrying Value | |||||||||
Series | Shares Outstanding at December 31, 2013 | Liquidation Preference per Share | At December 31, 2013 | At December 31, 2012 | |||||
(dollars in millions) | |||||||||
A | 44,000 | $ | 25,000 | $ | 1,100 | $ | 1,100 | ||
C | 519,882 | 1,000 | 408 | 408 | |||||
E | 34,500 | 25,000 | 862 | — | |||||
F | 34,000 | 25,000 | 850 | — | |||||
Total | $ | 3,220 | $ | 1,508 |
The Company's preferred stock qualifies as Tier 1 capital in accordance with regulatory capital requirements (see Note 14).
Series A Preferred Stock. In July 2006, the Company issued 44,000,000 Depositary Shares in an aggregate of $1,100 million. Each Depositary Share represents 1/1,000th of a Share of Floating Rate Non-Cumulative Preferred Stock, Series A, $0.01 par value (“Series A Preferred Stock”). The Series A Preferred Stock is redeemable at the Company's option, in whole or in part, on or after July 15, 2011 at a redemption price of $25,000 per share (equivalent to $25.00 per Depositary Share). The Series A Preferred Stock also has a preference over the Company's common stock upon liquidation. In December 2013, the Company declared a quarterly dividend of $255.56 per share of Series A Preferred Stock that was paid on January 15, 2014 to preferred shareholders of record on December 31, 2013.
Series B and Series C Preferred Stock. On October 13, 2008, the Company issued to MUFG 7,839,209 shares of Series B Preferred Stock and 1,160,791 shares of Series C Preferred Stock for an aggregate purchase price of $9 billion.
The Series C Preferred Stock is redeemable by the Company, in whole or in part, on or after October 15, 2011 at a redemption price of $1,100 per share. Dividends on the Series C Preferred Stock are payable, on a non-cumulative basis, as and if declared by the Board of Directors of the Company, in cash, at the rate of 10% per annum of the liquidation preference of $1,000 per share. In December 2013, the Company declared a quarterly dividend of $25.00 per share of Series C Preferred Stock that was paid on January 15, 2014 to preferred shareholders of record on December 31, 2013.
The $9 billion in proceeds was allocated to the Series B Preferred Stock and the Series C Preferred Stock based on their relative fair values at issuance (approximately $8.1 billion was allocated to the Series B Preferred Stock and approximately $0.9 billion to the Series C Preferred Stock). Upon redemption by the Company, the excess of the redemption value of $1,100 per share over the carrying value of the Series C Preferred Stock ($0.9 billion allocated at inception or approximately $784 per share) will be charged to Retained earnings (i.e., treated in a manner similar to the treatment of dividends paid). The amount charged to Retained earnings will be deducted from the numerator in calculating basic and diluted earnings per share during the related reporting period in which the Series C Preferred Stock is redeemed by the Company (see Note 16 for additional details).
During 2009, 640,909 shares of the Series C Preferred Stock were redeemed with an aggregate price equal to the aggregate price exchanged by MUFG for approximately $0.7 billion of common stock.
During 2011, the Company and MUFG completed the conversion of MUFG Series B Preferred Stock (see “MUFG Stock Conversion” above).
Series E Preferred Stock. On September 30, 2013, the Company issued 34,500,000 Depositary Shares, for an aggregate price of $862 million. Each Depositary Share represents a 1/1,000th interest in a share of perpetual Series E Fixed-to-Floating Rate Non-Cumulative Preferred Stock, $0.01 par value (“Series E Preferred Stock”). The Series E Preferred Stock is redeemable at the Company's option, (i) in whole or in part, from time to time, on any dividend payment date on or after October 15, 2023 or (ii) in whole but not in part at any time within 90 days following a regulatory capital treatment event (as described in the terms of that series), in each case at a redemption price of $25,000 per share (equivalent to $25.00 per Depository Share). The Series E Preferred Stock also has a preference over the Company's common stock upon liquidation. The Series E Preferred Stock offering (net of related issuance costs) resulted in proceeds of approximately $854 million. In December 2013, the Company declared a quarterly dividend of $519.53 per share of Series E Preferred Stock that was paid on January 15, 2014 to preferred shareholders of record on December 31, 2013.
Series F Preferred Stock. On December 10, 2013, the Company issued 34,000,000 Depositary Shares, for an aggregate price of $850 million. Each Depositary Share represents a 1/1,000th interest in a share of perpetual Series F Fixed-to-Floating Rate Non-Cumulative Preferred Stock, $0.01 par value (“Series F Preferred Stock”). The Series F Preferred Stock is redeemable at the Company's option, (i) in whole or in part, from time to time, on any dividend payment date on or after January 15, 2024 or (ii) in whole but not in part at any time within 90 days following a regulatory capital treatment event (as described in the terms of that series), in each case at a redemption price of $25,000 per share (equivalent to $25.00 per Depositary Share). The Series F Preferred Stock also has a preference over the Company's common stock upon liquidation. The Series F Preferred Stock offering (net of related issuance costs) resulted in proceeds of approximately $842 million. In December 2013, the Company declared the initial quarterly dividend of $167.10 per share of Series F Preferred Stock that was paid on January 15, 2014 to preferred shareholders of record on December 31, 2013.
Accumulated Other Comprehensive Loss.
The following table presents changes in AOCI by component, net of noncontrolling interests, in 2013 (dollars in millions):
Change in | |||||||||||||
Foreign | Net Change | Net Unrealized | Pension, | ||||||||||
Currency | in | Gains (Losses) on | Postretirement | ||||||||||
Translation | Cash Flow | Securities | and Other Related | ||||||||||
Adjustments | Hedges | Available for Sale | Adjustments | Total | |||||||||
Balance at December 31, 2012 | $ | (123) | $ | (5) | $ | 151 | $ | (539) | $ | (516) | |||
Other comprehensive income (loss) before | |||||||||||||
reclassifications | (143) | — | (406) | (16) | (565) | ||||||||
Amounts reclassified from AOCI | — | 4 | (27) | 11 | (12) | ||||||||
Net other comprehensive income (loss) during | |||||||||||||
the period | (143) | 4 | (433) | (5) | (577) | ||||||||
Balance at December 31, 2013 | $ | (266) | $ | (1) | $ | (282) | $ | (544) | $ | (1,093) |
The Company had no significant reclassifications out of AOCI for 2013.
Cumulative Foreign Currency Translation Adjustments. Cumulative foreign currency translation adjustments include gains or losses resulting from translating foreign currency financial statements from their respective functional currencies to U.S. dollars, net of hedge gains or losses and related tax effects. The Company uses foreign currency contracts to manage the currency exposure relating to its net investments in non-U.S. dollar functional currency subsidiaries. Increases or decreases in the value of the Company's net foreign investments generally are tax deferred for U.S. purposes, but the related hedge gains and losses are taxable currently. The Company attempts to protect its net book value from the effects of fluctuations in currency exchange rates on its net investments in non-U.S. dollar subsidiaries by selling the appropriate non-U.S. dollar currency in the forward market. Under some circumstances, however, the Company may elect not to hedge its net investments in certain foreign operations due to market conditions, including the availability of various currency contracts at acceptable costs. Information at December 31, 2013 and December 31, 2012 relating to the effects on cumulative foreign currency translation adjustments resulting from translation of foreign currency financial statements and from gains and losses from hedges of the Company's net investments in non-U.S. dollar functional currency subsidiaries is summarized below:
At | At | ||||
December 31, | December 31, | ||||
2013 | 2012 | ||||
(dollars in millions) | |||||
Net investments in non-U.S. dollar functional currency subsidiaries subject to hedges | $ | 11,708 | $ | 13,811 | |
Cumulative foreign currency translation adjustments resulting from net | |||||
investments in subsidiaries with a non-U.S. dollar functional currency | $ | (259) | $ | 348 | |
Cumulative foreign currency translation adjustments resulting from realized | |||||
or unrealized losses on hedges, net of tax(1) | (7) | (471) | |||
Total cumulative foreign currency translation adjustments, net of tax | $ | (266) | $ | (123) |
__________
(1) A gain of $77 million, net of tax, related to net investment hedges was reclassified from other comprehensive income into income during 2012. The amount primarily related to the reversal of amounts recorded in cumulative other comprehensive income due to the incorrect application of hedge accounting on certain derivative contracts (see Note 12 for further information).
Nonredeemable Noncontrolling Interests.
Changes in nonredeemable noncontrolling interests in 2013 primarily resulted from distributions related to MSMS of $292 million and a real estate fund of $214 million. In September 2012, the Company reclassified approximately $4.3 billion from nonredeemable noncontrolling interests to redeemable noncontrolling interests for Citi's remaining 35% interest in the Wealth Management JV (see Note 3). Changes in nonredeemable noncontrolling interests in 2012 also included distributions related to MSMS of $151 million.